https://www.selleckchem.com/products/nu7441.html
There is limited evidence describing the safety and effectiveness of bedaquiline and delamanid containing regimens in children and adolescents with Multidrug-Resistant Tuberculosis (MDR-T and Extensively Drug-Resistant Tuberculosis (XDR-T globally. In this nationwide descriptive cohort study from Belarus, we examined adverse drug events, time to culture conversion, treatment outcomes including post-treatment recurrence among children and adolescents ( less then 18 years of age) treated with bedaquiline and/or delamanid containing reg
Like
Comment
Share
